Insider Transactions in Q1 2022 at Insmed Inc (INSM)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
96,614
-11.92%
|
$2,222,122
$23.31 P/Share
|
|
Mar 23
2022
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,614
+10.03%
|
$1,449,210
$15.52 P/Share
|
|
Mar 01
2022
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
7,000
-1.0%
|
-
|
|
Mar 01
2022
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
2,000
+40.46%
|
-
|
|
Jan 12
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,217
-0.99%
|
$29,208
$24.58 P/Share
|
|
Jan 11
2022
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,154
-3.11%
|
$28,850
$25.11 P/Share
|
|
Jan 11
2022
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,495
-3.15%
|
$37,375
$25.11 P/Share
|
|
Jan 11
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
925
-1.6%
|
$23,125
$25.11 P/Share
|
|
Jan 11
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
407
-1.08%
|
$10,175
$25.11 P/Share
|
|
Jan 11
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,873
-1.3%
|
$71,825
$25.11 P/Share
|
|
Jan 06
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,458
+14.04%
|
-
|
|
Jan 06
2022
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,458
+20.0%
|
-
|
|
Jan 06
2022
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,741
+12.24%
|
-
|
|
Jan 06
2022
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,188
+22.99%
|
-
|
|
Jan 06
2022
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,006
+25.94%
|
-
|
|
Jan 06
2022
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,735
+12.59%
|
-
|
|
Jan 06
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
387
-1.35%
|
$10,062
$26.0 P/Share
|
|
Jan 06
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,612
-3.22%
|
$41,912
$26.0 P/Share
|
|
Jan 06
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,337
-2.74%
|
$138,762
$26.0 P/Share
|
|
Jan 06
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,759
-1.64%
|
$45,734
$26.0 P/Share
|
|
Jan 05
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
749
-2.54%
|
$20,223
$27.61 P/Share
|
|
Jan 05
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,503
-2.92%
|
$40,581
$27.61 P/Share
|
|
Jan 05
2022
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,423
-4.09%
|
$38,421
$27.61 P/Share
|
|
Jan 05
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
7,126
-3.52%
|
$192,402
$27.61 P/Share
|
|
Jan 05
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,068
-2.78%
|
$82,836
$27.61 P/Share
|